Development of NAALADase inhibitors: Toward the detection and treatment of prostate cancer.

被引:0
|
作者
Wiest, O
Picot, D
Wang, DF
Griffith, BD
Helquist, P
Miller, MJ
Tenniswood, M
机构
[1] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[2] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
101-MEDI
引用
收藏
页码:U192 / U192
页数:1
相关论文
共 50 条
  • [31] Angiogenesis inhibitors in the treatment of prostate cancer
    Kluetz, Paul G.
    Figg, William D.
    Dahut, William L.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 233 - 247
  • [32] Complexed PSA enhances specificity in the detection of prostate cancer.
    Cheli, CD
    Miller, MC
    Veltri, R
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : A128 - A128
  • [33] Toward Prostate Cancer Early Detection in Iran
    Mousavi, Seyed Mohsen
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (03) : 413 - 418
  • [34] PARP Inhibitors in the Treatment of Prostate Cancer: From Scientific Rationale to Clinical Development
    Kwon, Whi-An
    [J]. WORLD JOURNAL OF MENS HEALTH, 2024, 42 (02): : 290 - 303
  • [35] DEVELOPMENT OF PACE4 INHIBITORS AS A POTENTIAL TREATMENT AGAINST PROSTATE CANCER
    Kwiatkowska, A.
    Couture, F.
    Levesque, C.
    Ly, K.
    Day, R.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S36 - S37
  • [36] The development of a PSMA targeted imaging agent for prostate cancer.
    Byers, Jessie
    Berkman, Clifford
    Benny, Paul
    Porter, Tom
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [37] Development of a home PSA test for the screening of prostate cancer.
    Remaley, AT
    Chan, Y
    Samantha, B
    Hu, X
    Julie, P
    Ray, R
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : A138 - A138
  • [38] Development of PSMA-based immunotherapies for prostate cancer.
    Donovan, GP
    Morrissey, DM
    Arrigale, RA
    Zhan, CC
    Chodera, AJ
    Scalzo, TM
    Olson, WC
    Heston, WDW
    Israel, RJ
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 : 4558S - 4558S
  • [39] Genetic contribution of MYC to the development of primary prostate cancer.
    Whitlock, Nichelle C.
    Atway, Rayann
    Yang, Qi
    Ye, Huihui
    Sowalsky, Adam
    [J]. CANCER RESEARCH, 2018, 78 (16) : 110 - 110
  • [40] Addressing treatment resistance in models of lethal prostate cancer.
    Vasciaveo, Alessandro
    De Almeida, Francisca Nunes
    Zou, Min
    Di Bernardo, Matteo
    Califano, Andrea
    Abate-Shen, Cory
    [J]. CANCER RESEARCH, 2021, 81 (13)